Skip to content

Alpha Cognition ACOG Preferred Stock

Preferred Stock at other companies

Biogen logo
BiogenBIIB
$0
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$0
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$0
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$0

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's preferred stock?
Alpha Cognition (ACOG) reported preferred stock of $62 in Q1 2026.
How has Alpha Cognition's preferred stock changed year-over-year?
Alpha Cognition's preferred stock decreased by 0.0% year-over-year, from $62 to $62.
What is the long-term trend for Alpha Cognition's preferred stock?
Over 2 years (2023 to 2025), Alpha Cognition's preferred stock has grown at a 0.0% compound annual growth rate (CAGR), from $62 to $62.
What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.